In late December 2014, Valeant Pharmaceuticals voluntarily recalled a single lot of ribavirin powder, sold under the brand name Virazole, because there were concerns with the stability of the product. The FDA is aware of the recall and is working with the company to facilitate it.
The company says that 12-month testing of Lot 340353F showed a positive sterility test result, but the company did not identify what contaminated the powder. The medication was distributed throughout the United States and Australia. All other lots are unaffected and thus not involved in the recall. [click to continue…]
In mid-December, Baxter International recalled two lots of Sodium Chloride Injection. This particular recall affected 100-ML mini bags and containers of 0.9% sodium chloride. The recall was made voluntarily after the company received reports of particulate matter in the product. [click to continue…]
DeeDee Hu and Sapana Desai had no idea that on their flight from Houston to Los Angeles in mid-December would save a fellow passenger’s life. A passenger on the flight lost consciousness and had no pulse, but thanks to a pair of pharmacists onboard who work at Memorial Hermann Memorial City Medical Center in Houston, the passenger was okay. Both Desai and Hu were on the flight for the American Society of Health-System Pharmacists (ASHP) midyear clinical meeting. [click to continue…]
Heart disease remains the number one cause of death for both men and women in the United States. One in four deaths is caused by heart disease. The good news is that heart disease can be prevented by encouraging people to make healthy choices and manage their current health conditions. As pharmacists, you can work together with your patients and the community to provide opportunities that allow people to make healthier choices. [click to continue…]
The National Institute for Occupational Safety and Health (NIOSH) made a revision to the list of hazardous drugs found in health care facilities. The latest update, made in late November, now accounts for workers’ exposure risks, and now categorizes drugs by type. [click to continue…]
January 1 marks the beginning of phased-in implementation of the FDA’s tracking and pedigree regulations for medications, while the first major pharmacy requirements go into effect in July.
Beginning this month, drug manufacturers and distributors must provide pharmacies with specific transaction information. They must provide a transaction history and statement that indicates product shipments down to the lot level. This change is a result of the Drug Supply Chain Security Act of 2013. [click to continue…]